Phocaeicola dorei: A Common Bacteroides-Family Gut Resident

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Detects the abundance of Phocaeicola dorei in your gut microbiome to identify microbial imbalances. Knowing your P. dorei level can help guide diet, probiotic, or lifestyle changes that may reduce risk of gut inflammation and related immune or metabolic issues.

Read more →

Understand what your gut health results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Pinpointing a common Bacteroides-family resident

A phocaeicola dorei test measures the amount of a specific gut bacterium—formerly called Bacteroides dorei—in your stool. Most labs quantify it by sequencing DNA from the sample, either with targeted 16S rRNA profiling or deeper metagenomic analysis. Because the short 16S V4 region can blur P. dorei with its close cousin P. vulgatus, some reports use longer-read sequencing or a species‑specific qPCR to improve specificity. Results show the relative abundance (your percentage compared with total microbes), reflecting your current microbiome state rather than a fixed trait. The species’ modern taxonomy places Bacteroides dorei within the Phocaeicola genus, so you may see either name in reports.

Why does this niche species matter? Phocaeicola dorei participates in breaking down complex carbohydrates and contributes to short‑chain fatty acid pools that help fuel colon cells, calm immune signaling, and support the gut barrier. It’s one of the common Bacteroidetes players in human stool—especially alongside P. vulgatus—so its level gives a window into a “Bacteroides‑forward” ecology that influences digestion, metabolic tone, and aspects of immune education. As with all microbiome measures, interpretation lives in context: diet, geography, and life stage can reshape what “balanced” looks like for you.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why a Bacteroides-forward signal is worth reading

Testing connects a real bacterium to real‑world questions: Is your gut community diversified and stable, or leaning heavily on a few dominant species? Higher P. dorei often rides with a Bacteroides‑dominant pattern shaped by low fiber, higher fat/protein eating, and recent antibiotics. That profile can coincide with lower overall diversity—think lots of one artist on your playlist—which may mean less functional redundancy for tasks like fiber fermentation and barrier support. In early‑life research, a transient spike in B. dorei (the prior name) preceded islet autoimmunity in genetically high‑risk Finnish infants, suggesting a potential early microbial signal though not proof of causation. In parallel, Bacteroides lipopolysaccharide (LPS) appears less immunostimulatory than E. coli LPS, which may alter innate “training” in infancy—again, a mechanistic clue rather than a clinical directive.

Zoom out and P. dorei becomes a marker of systems biology, not a verdict. The P. dorei–P. vulgatus duo is among the most ubiquitous gut residents worldwide, evolving with us and adapting to our diets. Watching this signal over time helps you see how fiber intake, diversity of plant foods, and recovery after antibiotics show up in your microbiome. The goal isn’t a perfect number but patterns: how your gut ecosystem responds, stabilizes, and supports digestion, energy, and immune steadiness as life changes.

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

Reading the number in community context

Your results typically report P. dorei as a proportion of total microbes, sometimes benchmarked to a reference population. In many healthy adults, moderate representation of P. dorei within a diverse community is common. When P. dorei is high alongside other Bacteroides, it often signals a Bacteroides‑dominant enteric pattern, which can occur with lower fiber or after antibiotics; when it’s very low amid rich diversity, you may be seeing a Prevotella‑ or Firmicutes‑leaning pattern. “Normal” varies widely by diet, geography, and life stage, so it’s more about the community context than a single cut‑off.

Balanced ranges usually imply efficient carbohydrate breakdown, steady short‑chain fatty acid production, and a calm barrier. If P. dorei is disproportionately high, that can coincide with lower diversity or inflammation‑prone patterns in some settings; if very low, you may simply reside in a different, equally viable “ecotype.” In infants with specific genetics, research linked a transient surge in B. dorei to later islet autoimmunity, but that association does not establish causation and does not translate into stand‑alone screening or treatment decisions.

Big picture: P. dorei is most useful when viewed alongside other reads—overall diversity, other keystone species, stool inflammatory markers, and metabolic labs—and interpreted over time. Because most assays report relative abundance, it’s helpful to track trends and correlate with real changes in diet, stress, sleep, and medication use. That’s how you turn a single species into practical insight about digestion, energy, and long‑term gut resilience.

Credibility cues and test limitations

Selected research touchpoints

Why two Phocaeicola dorei tests can disagree

Taxonomy matters: Bacteroides dorei has been reclassified as Phocaeicola dorei, so reports may use either name. P. dorei and P. vulgatus are closely related; short‑read 16S (V4) alone may not separate them cleanly, and labs often use longer reads or species‑specific assays to improve resolution. Stool testing reflects relative abundance rather than absolute counts unless targeted qPCR is included. Day‑to‑day variation, sample handling, and lab pipelines can shift percentages. Finally, associations are not causation—P. dorei is a helpful lens on ecology and immune tone, not a diagnosis or a treatment target.

Frequently Asked Questions

References

  1. Davis-Richardson AG, Ardissone AN, Dias R, Simell V, Leonard MT, Kemppainen KM, Drew JC, Schatz D, Atkinson MA, Kolaczkowski B, Ilonen J, Knip M, Toppari J, Nurminen N, Hyöty H, Veijola R, Simell T, Mykkänen J, Simell O, Triplett EW (2014). Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. *Frontiers in Microbiology*, *5*, 678. https://doi.org/10.3389/fmicb.2014.00678
  2. Vatanen T, Kostic AD, d'Hennezel E, Siljander H, Franzosa EA, Yassour M, Kolde R, Vlamakis H, Arthur TD, Hämäläinen AM, Peet A, Tillmann V, Uibo R, Mokurov S, Dorshakova N, Ilonen J, Virtanen SM, Szabo SJ, Porter JA, ... Xavier RJ (2016). Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. *Cell*, *165*(4), 842-853. https://doi.org/10.1016/j.cell.2016.04.007
  3. Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F, Lener E, Mele MC, Gasbarrini A, Collado MC, Cammarota G, Ianiro G (2023). Short-chain fatty-acid-producing bacteria: Key components of the human gut microbiota. *Nutrients*, *15*(9), 2211. https://doi.org/10.3390/nu15092211
  4. Jovel J, Patterson J, Wang W, Hotte N, O'Keefe S, Mitchel T, Perry T, Kao D, Mason AL, Madsen KL, Wong, G. K.-S. (2016). Characterization of the gut microbiome using 16S or shotgun metagenomics. *Frontiers in Microbiology*, *7*, 459. https://doi.org/10.3389/fmicb.2016.00459
  5. Drago L (2025). Navigating microbiome variability: Implications for research, diagnostics, and direct-to-consumer testing. *Frontiers in Microbiology*, *16*, 1580531. https://doi.org/10.3389/fmicb.2025.1580531

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Biological age 32 — a Superpower member portraitA health system built around you — test, understand, optimize150+ biomarkers across 2 blood drawsWhat to expect with Superpower — week 1 to month 3Trusted by 64,000+ customers — member reviewsBetter than the status quo — Superpower vs the old way60% of members found something a doctor missed — member survey
Daniel OSuperpower memberDavid LSuperpower memberRachel DSuperpower memberCamelia VSuperpower member

4.6 · 64,000+ members

Superpower health membership

Find early signs of 1,000+ conditions - then act, retest, and see what changed.

$199

$349

/year*

Limited time: $150 off

150+ biomarkers annually across baseline + retest

Personalized plan that turns results into action

Superpower AI and on-demand care team

Results in 10 days or less

At-home or 2,000+ labs nationwide**

Yearly membership$0.55 / dayHSA/FSA eligible

*Pricing may vary for members in New York and New Jersey

**At-home labs for an additional cost

What we test

TestosteroneFree T4Vitamin DApoBHbA1cThyroid (TSH)hs-CRPFerritinCortisolFasting insulin

60%

found something a doctor missed

93%

rated it more useful than their checkup

77%

found something new in their results

Superpower member survey, 90 days post action plan (n=143).

How does the Superpower membership work?

We test 150+ biomarkers annually across two blood draws. Your baseline test paints a comprehensive picture of your health, and your dashboard shows what’s working, what needs attention, and what to do next. Superpower AI and your care team help you take action across lifestyle, supplements, and treatments. Then we retest to track your progress and continue refining your plan.

Can I cancel anytime?

Yes. You can cancel anytime, no fees. Your membership stays active through the end of your paid year.

How often should I test?

Your membership includes two blood tests per year: one to establish your baseline, and one to see whether your plan improved biomarkers that were out of range or not yet optimized. You can add other diagnostics anytime through the app or with help from your care team.

When will I get my results?

Book your draw at any of 2,000+ partner labs or at-home. Results are typically ready in about a week and land in the Superpower app.

What the 100+ panel measures

All 101 markers in your annual baseline draw, organized by system. Nothing here is an upsell.

Heart & Vascular Health

26

  • Apolipoprotein B
  • Atherogenic Coefficient
  • Atherogenic Index of Plasma
  • Castelli Risk Index I
  • Castelli Risk Index II
  • HDL Cholesterol
  • LDL Cholesterol
  • LDL/HDL Ratio
  • Cholesterol, Total
  • Non-HDL Cholesterol
  • Cholesterol/HDL Ratio
  • Carbon Dioxide, Total
  • High-sensitivity CRP
  • hsCRP-to-Albumin Ratio (CAR)
  • GGT-to-HDL Cholesterol Ratio
  • LDL-C to Apolipoprotein B Ratio (LDL-C/ApoB)
  • LDL Cholesterol / Total Cholesterol (Mass Ratio)
  • Monocyte-to-HDL Ratio (MHR)
  • Neutrophil-to-HDL Cholesterol Ratio (NHR)
  • Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB)
  • NON-HDL Total Cholesterol Ratio
  • Triglyceride HDL Molar Ratio
  • Triglycerides
  • Triglyceride-to-Apolipoprotein B Ratio (TG/ApoB)
  • TyG Index
  • Uric Acid

Metabolic Health

4

  • Estim. Avg Glu (eAG)
  • Eag (mmol/l)
  • Glucose
  • Hemoglobin A1c

Energy

1

  • Cortisol

Liver Health

15

  • Albumin/Globulin Ratio
  • Albumin
  • Alkaline Phosphatase (ALP)
  • Alanine Aminotransferase (ALT)
  • Aspartate Aminotransferase (AST)
  • Bilirubin Direct
  • Bilirubin Indirect
  • Bilirubin, Total
  • Bilirubin-to-Albumin Ratio
  • Ferritin
  • Ferritin-to-Albumin Ratio
  • y-Glutamyl Transferase (GGT)
  • Globulin, Total
  • Indirect-to-Direct Bilirubin Ratio
  • Protein, Total

Kidney

11

  • Calcium
  • Chloride
  • Corrected Calcium (Albumin-adjusted)
  • Creatinine
  • Estimated Glomerular Filtration Rate (eGFR)
  • Potassium
  • Sodium
  • BUN/Creatinine Ratio
  • Blood Urea Nitrogen (BUN)
  • Urea-to-Creatinine Ratio
  • Uric Acid-to-HDL Cholesterol Ratio (UHR)

Sex Hormones

7

  • DHEA-Sulfate (DHEA-S)
  • Free Androgen Index
  • Sex Hormone Binding Globulin (SHBG)
  • Free Testosterone
  • Testosterone, Bioavailable
  • Testosterone, Total
  • Testosterone-to-Estradiol Ratio (T/E₂)

Thyroid Health

4

  • Free Thyroxine Index
  • T3 Uptake
  • T4 (thyroxine) Total
  • Thyroid-Stimulating Hormone (TSH)

Nutrients

13

  • Vitamin D
  • Red Cell Dist Width (RDW)
  • Hematocrit
  • Hemoglobin
  • Total Iron Binding Capacity (TIBC)
  • Iron
  • Iron Saturation
  • Mean Cell Hemoglobin (MCH)
  • Mean Corpuscular Hemoglobin Concentration (MCHC)
  • Mean Cell Volume (MCV)
  • Platelet-to-WBC Ratio (PWR)
  • Red Blood Cells
  • RDW MCV Ratio

Immune System

12

  • Basophils
  • Baso (Absolute)
  • Eosinophils
  • Eos (Absolute)
  • Lymphocytes
  • Lymphs (Absolute)
  • Monocytes
  • Monocytes (Absolute)
  • Neutrophils
  • Neutrophils (Absolute)
  • Mean Platelet Volume
  • Platelet Count

Inflammation

8

  • Lymphocyte-to-Monocyte Ratio (LMR)
  • Monocyte-to-Lymphocyte Ratio (MLR)
  • Neutrophil-to-Lymphocyte-Platelet Ratio (NLPR)
  • Neutrophil-to-Lymphocyte Ratio (NLR)
  • Platelet-to-Lymphocyte Ratio (PLR)
  • Systemic Immune-Inflammation Index
  • Systemic Inflammation Response Index (SIRI)
  • White Blood Cells
Get my health baseline

The full list of 100+ markers and 8 specialty add-ons available at superpower.com/biomarkers.